. Author manuscript; available in PMC: 2012 Apr 5.

Published in final edited form as: Nanomedicine (Lond). 2011 Dec 21;7(4):553–564. doi: 10.2217/nnm.11.145

Table 2.

Parthenogenetic activation using SrCl₂ solution for oocytes retrieved after harvesting (control) and after encapsulation in medium droplets followed by ejection into medium.

Experimental groups	SrCl₂ concentration (mM)	Number of oocytes initiated	Number of oocytes cleaved (%)	Blastocytes developed (%)
Control	10	81	3 (3.7)	0 (0)
	20	82	38 (46.3)	13 (15.9)
	50	79	70 (88.6)^†	33 (49.4)^‡
	100	88	43 (48.9)	2 (2.3)

Ejection with medium	50	100	96 (97.0)^†	26 (26.0)^‡

^†

Values are significantly different (p < 0.01).

^‡

Values are significantly different (p < 0.01).